Neurodegeneration / en Mon, 16 Jun 25 14:11:15 -0400 #WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research /news/whyiscienceqa-neuroscientist-advocates-stepping-outside-your-comfort-zone-research <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Allessandra DiCorato</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" class="datetime">June 16, 2025</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Giulia Monti reflects on how studying Alzheimer’s disease alongside researchers focused on kidney disease has helped her grow as a scientist.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Allessandra DiCorato </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" title="Monday, June 16, 2025 - 14:11" class="datetime">June 16, 2025</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1921px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=RibMLmfO 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/jpeg" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=9EVBDViv 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/jpeg" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=EfGmefhO 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/jpeg" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG 1x" media="all and (max-width: 539px)" type="image/jpeg" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG" alt="headshot of Giulia Monti" title="headshot of Giulia Monti" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__credit"> Credit: Allison Colorado, ӳý Communications </div> <div class="media-caption__description"> Giulia Monti studies Alzheimer's disease in the lab of Anna Greka. </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/2311/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/2311/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/2311/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--whyiscience-links paragraph--view-mode--default"> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p>At first, Giulia Monti thought she’d work in another neuroscience lab as a postdoctoral researcher. She had spent the last four years earning her PhD at Aarhus University in Denmark, studying proteins called cargo receptors in Alzheimer’s disease.</p> <p>But then she stumbled upon the lab of <a href="/node/14871">Anna Greka</a>, a core institute member at the ӳý and a nephrologist at Mass General Brigham. The Greka lab studies the mechanisms behind protein trafficking inside cells, similar to what Monti researched in graduate school, but in the context of the kidney. Greka’s team had discovered that a family of cargo receptors called TMEDs traps misfolded proteins in the kidney, leading to kidney failure. They even found that this pathway also caused disease in the eye, suggesting that therapies developed to target this <a href="/news/molecular-traffic-jam-may-underlie-rare-kidney-disease-and-several-other-protein-misfolding">“node”</a> might be able to treat multiple diseases.</p> <p>Monti was intrigued by the parallels with her own work on misfolded proteins in neurodegeneration. She began to think about how she might study her original questions in a fresh context, beyond her usual area of expertise.</p> <p>“I thought that this was where I could learn the most,” said Monti, who is originally from Como, Italy, and completed a master’s degree in pharmacy at the University of Milan. “Being around researchers with different expertise challenged my thinking and broadened my learning in ways I had not anticipated. I love the idea of studying biology at its core, where the same basic principles can apply across different systems.”</p> <p>In December 2022, Monti moved to the US and joined the Greka lab as a postdoctoral associate. Today, she uses induced pluripotent stem (iPS) cells, mouse models, biochemical assays, and high-throughput screening to study the role of TMED cargo receptors in Alzheimer’s disease. She also collaborates with the lab of <a href="/node/1141681">Sam Peng</a> at ӳý, using single-particle tracking to visualize how proteins move inside neurons.</p> <p>We spoke with Monti about how her childhood curiosity evolved into her current interests in neuroscience and Alzheimer’s disease, and what drives her to seek new environments in this #WhyIScienceQ&A.</p> <p><strong>What got you interested in research?</strong></p> <p>Since I started school, I’ve been driven by wanting to understand how and why things happen.  For me, acquiring knowledge wasn’t just about school, it was how I could explore and make sense of the world.</p> <p>The brain has always fascinated me because it's been studied extensively and yet is still full of mysteries. I was deeply interested in biology and medicine, and I realized early on that my best fit was to directly work at the bench to contribute to the development of treatments for patients.  Science seemed to me the perfect outlet for my curiosity.</p> <p>During my undergrad, I had the opportunity to work in a lab where I actually realized that a career in research was not only possible but also incredibly rewarding. The curiosity-driven aspect of academic research appealed to me because it allows you to explore multiple paths. Of course, you want to help patients, and you need to steer your path with that goal in mind. But the idea that one can fundamentally ask any question to understand mechanistic biology — that's what made research the right path for me.</p> <p><strong>What are you working on right now?</strong></p> <p>We want to learn about nodal biology to translate it into something meaningful for Alzheimer’s patients. And we actually have some interesting results. We think the TMED cargo receptors previously discovered by the Greka lab also play a role in Alzheimer's disease. We found that they can bind to the amyloid precursor protein that’s known to be linked to Alzheimer’s disease. It seems that these cargo receptors are important for the trafficking of these amyloid proteins in the early secretory pathway, and therefore they can actually play a role not only in the trafficking of the protein, but also in the processing of amyloid itself, which ultimately leads to prevention of amyloid plaque deposition in the brain.</p> <p>This could be extremely meaningful for patients. Now that we have identified the target, we can begin to think more from a translational angle, exploring therapeutic possibilities that could alleviate the pathology also in Alzheimer’s patients.</p> <p><strong>What questions do you find most exciting in Alzheimer’s research today?</strong></p> <p>I think it's exciting to think about a major paradigm shift in Alzheimer's disease research. In the field, the vast majority of clinical trials focus on removing extracellular amyloid plaques deposited in the brain. However, this approach may target the disease at a stage that is already too advanced to observe substantial clinical benefits. Shifting the focus to alternative targets could redefine the way we think about the disease and treatment strategies. </p> <p>We should start looking more at the processes occurring inside neurons rather than just outside the cells, especially at the earliest stages of the disease. The amyloid in the extracellular space could be like the smoke and not the fire. Removing the smoke may provide temporary relief, but it won’t solve the problem in the long run if the fire continues to burn. By studying the early secretory pathways where proteins are sorted within the cell, even before reaching the late secretary stages that much of Alzheimer’s research currently targets — we would gain a lot of knowledge and possibly begin to shift the paradigm that way.</p> <p><strong>What advice would you give your younger self?</strong></p> <p>I would never have thought to be part of an institute such as the ӳý. I'm proud of the courage it took to leave my family and friends in Italy for grad school, and of how much I pushed myself along the way. During my PhD, I went to the University of Washington to learn from a lab that specialized in iPS cells for a couple of months. Even though it was a short stay, it had a big impact on me . I could actually see myself pursuing research in the US. The environment was incredibly inspiring, and it was energizing to be around people who are deeply passionate about what they do.</p> <p>And so I would advise: Do not fear change. Travel as much as you can for research, and try to experience as many different environments as you can. Don't be afraid of the challenge. You can gain a lot of knowledge from this experience. The reward will be so meaningful that the struggle will be less important.</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/neurodegeneration" hreflang="en">Neurodegeneration</a></div> <div class="field__item"><a href="/broad-tags/psychiatric-disease" hreflang="en">Brain Health</a></div> <div class="field__item"><a href="/broad-tags/anna-greka" hreflang="en">Anna Greka</a></div> </div> </div> </div> </div> </div> Mon, 16 Jun 2025 18:11:15 +0000 adicorat 5558766 at Potential Alzheimer’s disease therapeutic target identified in brain immune cells /news/potential-alzheimers-disease-therapeutic-target-identified-brain-immune-cells <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Allessandra DiCorato</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" class="datetime">June 16, 2025</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Giulia Monti reflects on how studying Alzheimer’s disease alongside researchers focused on kidney disease has helped her grow as a scientist.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Allessandra DiCorato </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" title="Monday, June 16, 2025 - 14:11" class="datetime">June 16, 2025</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1921px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=RibMLmfO 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/jpeg" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=9EVBDViv 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/jpeg" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=EfGmefhO 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/jpeg" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG 1x" media="all and (max-width: 539px)" type="image/jpeg" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG" alt="headshot of Giulia Monti" title="headshot of Giulia Monti" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__credit"> Credit: Allison Colorado, ӳý Communications </div> <div class="media-caption__description"> Giulia Monti studies Alzheimer's disease in the lab of Anna Greka. </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/2311/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/2311/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/2311/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--whyiscience-links paragraph--view-mode--default"> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p>At first, Giulia Monti thought she’d work in another neuroscience lab as a postdoctoral researcher. She had spent the last four years earning her PhD at Aarhus University in Denmark, studying proteins called cargo receptors in Alzheimer’s disease.</p> <p>But then she stumbled upon the lab of <a href="/node/14871">Anna Greka</a>, a core institute member at the ӳý and a nephrologist at Mass General Brigham. The Greka lab studies the mechanisms behind protein trafficking inside cells, similar to what Monti researched in graduate school, but in the context of the kidney. Greka’s team had discovered that a family of cargo receptors called TMEDs traps misfolded proteins in the kidney, leading to kidney failure. They even found that this pathway also caused disease in the eye, suggesting that therapies developed to target this <a href="/news/molecular-traffic-jam-may-underlie-rare-kidney-disease-and-several-other-protein-misfolding">“node”</a> might be able to treat multiple diseases.</p> <p>Monti was intrigued by the parallels with her own work on misfolded proteins in neurodegeneration. She began to think about how she might study her original questions in a fresh context, beyond her usual area of expertise.</p> <p>“I thought that this was where I could learn the most,” said Monti, who is originally from Como, Italy, and completed a master’s degree in pharmacy at the University of Milan. “Being around researchers with different expertise challenged my thinking and broadened my learning in ways I had not anticipated. I love the idea of studying biology at its core, where the same basic principles can apply across different systems.”</p> <p>In December 2022, Monti moved to the US and joined the Greka lab as a postdoctoral associate. Today, she uses induced pluripotent stem (iPS) cells, mouse models, biochemical assays, and high-throughput screening to study the role of TMED cargo receptors in Alzheimer’s disease. She also collaborates with the lab of <a href="/node/1141681">Sam Peng</a> at ӳý, using single-particle tracking to visualize how proteins move inside neurons.</p> <p>We spoke with Monti about how her childhood curiosity evolved into her current interests in neuroscience and Alzheimer’s disease, and what drives her to seek new environments in this #WhyIScienceQ&A.</p> <p><strong>What got you interested in research?</strong></p> <p>Since I started school, I’ve been driven by wanting to understand how and why things happen.  For me, acquiring knowledge wasn’t just about school, it was how I could explore and make sense of the world.</p> <p>The brain has always fascinated me because it's been studied extensively and yet is still full of mysteries. I was deeply interested in biology and medicine, and I realized early on that my best fit was to directly work at the bench to contribute to the development of treatments for patients.  Science seemed to me the perfect outlet for my curiosity.</p> <p>During my undergrad, I had the opportunity to work in a lab where I actually realized that a career in research was not only possible but also incredibly rewarding. The curiosity-driven aspect of academic research appealed to me because it allows you to explore multiple paths. Of course, you want to help patients, and you need to steer your path with that goal in mind. But the idea that one can fundamentally ask any question to understand mechanistic biology — that's what made research the right path for me.</p> <p><strong>What are you working on right now?</strong></p> <p>We want to learn about nodal biology to translate it into something meaningful for Alzheimer’s patients. And we actually have some interesting results. We think the TMED cargo receptors previously discovered by the Greka lab also play a role in Alzheimer's disease. We found that they can bind to the amyloid precursor protein that’s known to be linked to Alzheimer’s disease. It seems that these cargo receptors are important for the trafficking of these amyloid proteins in the early secretory pathway, and therefore they can actually play a role not only in the trafficking of the protein, but also in the processing of amyloid itself, which ultimately leads to prevention of amyloid plaque deposition in the brain.</p> <p>This could be extremely meaningful for patients. Now that we have identified the target, we can begin to think more from a translational angle, exploring therapeutic possibilities that could alleviate the pathology also in Alzheimer’s patients.</p> <p><strong>What questions do you find most exciting in Alzheimer’s research today?</strong></p> <p>I think it's exciting to think about a major paradigm shift in Alzheimer's disease research. In the field, the vast majority of clinical trials focus on removing extracellular amyloid plaques deposited in the brain. However, this approach may target the disease at a stage that is already too advanced to observe substantial clinical benefits. Shifting the focus to alternative targets could redefine the way we think about the disease and treatment strategies. </p> <p>We should start looking more at the processes occurring inside neurons rather than just outside the cells, especially at the earliest stages of the disease. The amyloid in the extracellular space could be like the smoke and not the fire. Removing the smoke may provide temporary relief, but it won’t solve the problem in the long run if the fire continues to burn. By studying the early secretory pathways where proteins are sorted within the cell, even before reaching the late secretary stages that much of Alzheimer’s research currently targets — we would gain a lot of knowledge and possibly begin to shift the paradigm that way.</p> <p><strong>What advice would you give your younger self?</strong></p> <p>I would never have thought to be part of an institute such as the ӳý. I'm proud of the courage it took to leave my family and friends in Italy for grad school, and of how much I pushed myself along the way. During my PhD, I went to the University of Washington to learn from a lab that specialized in iPS cells for a couple of months. Even though it was a short stay, it had a big impact on me . I could actually see myself pursuing research in the US. The environment was incredibly inspiring, and it was energizing to be around people who are deeply passionate about what they do.</p> <p>And so I would advise: Do not fear change. Travel as much as you can for research, and try to experience as many different environments as you can. Don't be afraid of the challenge. You can gain a lot of knowledge from this experience. The reward will be so meaningful that the struggle will be less important.</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/neurodegeneration" hreflang="en">Neurodegeneration</a></div> <div class="field__item"><a href="/broad-tags/psychiatric-disease" hreflang="en">Brain Health</a></div> <div class="field__item"><a href="/broad-tags/anna-greka" hreflang="en">Anna Greka</a></div> </div> </div> </div> </div> </div> Wed, 09 Apr 2025 13:36:41 +0000 Corie Lok 5558456 at Study finds surprising way that genetic mutation causes Huntington’s disease, transforming understanding of the disorder /news/study-finds-surprising-way-genetic-mutation-causes-huntingtons-disease-transforming <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Allessandra DiCorato</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" class="datetime">June 16, 2025</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Giulia Monti reflects on how studying Alzheimer’s disease alongside researchers focused on kidney disease has helped her grow as a scientist.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Allessandra DiCorato </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" title="Monday, June 16, 2025 - 14:11" class="datetime">June 16, 2025</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1921px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=RibMLmfO 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/jpeg" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=9EVBDViv 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/jpeg" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=EfGmefhO 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/jpeg" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG 1x" media="all and (max-width: 539px)" type="image/jpeg" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG" alt="headshot of Giulia Monti" title="headshot of Giulia Monti" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__credit"> Credit: Allison Colorado, ӳý Communications </div> <div class="media-caption__description"> Giulia Monti studies Alzheimer's disease in the lab of Anna Greka. </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/2311/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/2311/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/2311/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--whyiscience-links paragraph--view-mode--default"> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p>At first, Giulia Monti thought she’d work in another neuroscience lab as a postdoctoral researcher. She had spent the last four years earning her PhD at Aarhus University in Denmark, studying proteins called cargo receptors in Alzheimer’s disease.</p> <p>But then she stumbled upon the lab of <a href="/node/14871">Anna Greka</a>, a core institute member at the ӳý and a nephrologist at Mass General Brigham. The Greka lab studies the mechanisms behind protein trafficking inside cells, similar to what Monti researched in graduate school, but in the context of the kidney. Greka’s team had discovered that a family of cargo receptors called TMEDs traps misfolded proteins in the kidney, leading to kidney failure. They even found that this pathway also caused disease in the eye, suggesting that therapies developed to target this <a href="/news/molecular-traffic-jam-may-underlie-rare-kidney-disease-and-several-other-protein-misfolding">“node”</a> might be able to treat multiple diseases.</p> <p>Monti was intrigued by the parallels with her own work on misfolded proteins in neurodegeneration. She began to think about how she might study her original questions in a fresh context, beyond her usual area of expertise.</p> <p>“I thought that this was where I could learn the most,” said Monti, who is originally from Como, Italy, and completed a master’s degree in pharmacy at the University of Milan. “Being around researchers with different expertise challenged my thinking and broadened my learning in ways I had not anticipated. I love the idea of studying biology at its core, where the same basic principles can apply across different systems.”</p> <p>In December 2022, Monti moved to the US and joined the Greka lab as a postdoctoral associate. Today, she uses induced pluripotent stem (iPS) cells, mouse models, biochemical assays, and high-throughput screening to study the role of TMED cargo receptors in Alzheimer’s disease. She also collaborates with the lab of <a href="/node/1141681">Sam Peng</a> at ӳý, using single-particle tracking to visualize how proteins move inside neurons.</p> <p>We spoke with Monti about how her childhood curiosity evolved into her current interests in neuroscience and Alzheimer’s disease, and what drives her to seek new environments in this #WhyIScienceQ&A.</p> <p><strong>What got you interested in research?</strong></p> <p>Since I started school, I’ve been driven by wanting to understand how and why things happen.  For me, acquiring knowledge wasn’t just about school, it was how I could explore and make sense of the world.</p> <p>The brain has always fascinated me because it's been studied extensively and yet is still full of mysteries. I was deeply interested in biology and medicine, and I realized early on that my best fit was to directly work at the bench to contribute to the development of treatments for patients.  Science seemed to me the perfect outlet for my curiosity.</p> <p>During my undergrad, I had the opportunity to work in a lab where I actually realized that a career in research was not only possible but also incredibly rewarding. The curiosity-driven aspect of academic research appealed to me because it allows you to explore multiple paths. Of course, you want to help patients, and you need to steer your path with that goal in mind. But the idea that one can fundamentally ask any question to understand mechanistic biology — that's what made research the right path for me.</p> <p><strong>What are you working on right now?</strong></p> <p>We want to learn about nodal biology to translate it into something meaningful for Alzheimer’s patients. And we actually have some interesting results. We think the TMED cargo receptors previously discovered by the Greka lab also play a role in Alzheimer's disease. We found that they can bind to the amyloid precursor protein that’s known to be linked to Alzheimer’s disease. It seems that these cargo receptors are important for the trafficking of these amyloid proteins in the early secretory pathway, and therefore they can actually play a role not only in the trafficking of the protein, but also in the processing of amyloid itself, which ultimately leads to prevention of amyloid plaque deposition in the brain.</p> <p>This could be extremely meaningful for patients. Now that we have identified the target, we can begin to think more from a translational angle, exploring therapeutic possibilities that could alleviate the pathology also in Alzheimer’s patients.</p> <p><strong>What questions do you find most exciting in Alzheimer’s research today?</strong></p> <p>I think it's exciting to think about a major paradigm shift in Alzheimer's disease research. In the field, the vast majority of clinical trials focus on removing extracellular amyloid plaques deposited in the brain. However, this approach may target the disease at a stage that is already too advanced to observe substantial clinical benefits. Shifting the focus to alternative targets could redefine the way we think about the disease and treatment strategies. </p> <p>We should start looking more at the processes occurring inside neurons rather than just outside the cells, especially at the earliest stages of the disease. The amyloid in the extracellular space could be like the smoke and not the fire. Removing the smoke may provide temporary relief, but it won’t solve the problem in the long run if the fire continues to burn. By studying the early secretory pathways where proteins are sorted within the cell, even before reaching the late secretary stages that much of Alzheimer’s research currently targets — we would gain a lot of knowledge and possibly begin to shift the paradigm that way.</p> <p><strong>What advice would you give your younger self?</strong></p> <p>I would never have thought to be part of an institute such as the ӳý. I'm proud of the courage it took to leave my family and friends in Italy for grad school, and of how much I pushed myself along the way. During my PhD, I went to the University of Washington to learn from a lab that specialized in iPS cells for a couple of months. Even though it was a short stay, it had a big impact on me . I could actually see myself pursuing research in the US. The environment was incredibly inspiring, and it was energizing to be around people who are deeply passionate about what they do.</p> <p>And so I would advise: Do not fear change. Travel as much as you can for research, and try to experience as many different environments as you can. Don't be afraid of the challenge. You can gain a lot of knowledge from this experience. The reward will be so meaningful that the struggle will be less important.</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/neurodegeneration" hreflang="en">Neurodegeneration</a></div> <div class="field__item"><a href="/broad-tags/psychiatric-disease" hreflang="en">Brain Health</a></div> <div class="field__item"><a href="/broad-tags/anna-greka" hreflang="en">Anna Greka</a></div> </div> </div> </div> </div> </div> Thu, 16 Jan 2025 16:00:00 +0000 adicorat 5558011 at Gene editing extends lifespan in mouse model of prion disease /news/gene-editing-extends-lifespan-mouse-model-prion-disease <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Allessandra DiCorato</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" class="datetime">June 16, 2025</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Giulia Monti reflects on how studying Alzheimer’s disease alongside researchers focused on kidney disease has helped her grow as a scientist.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Allessandra DiCorato </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" title="Monday, June 16, 2025 - 14:11" class="datetime">June 16, 2025</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1921px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=RibMLmfO 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/jpeg" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=9EVBDViv 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/jpeg" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=EfGmefhO 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/jpeg" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG 1x" media="all and (max-width: 539px)" type="image/jpeg" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG" alt="headshot of Giulia Monti" title="headshot of Giulia Monti" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__credit"> Credit: Allison Colorado, ӳý Communications </div> <div class="media-caption__description"> Giulia Monti studies Alzheimer's disease in the lab of Anna Greka. </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/2311/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/2311/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/2311/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--whyiscience-links paragraph--view-mode--default"> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p>At first, Giulia Monti thought she’d work in another neuroscience lab as a postdoctoral researcher. She had spent the last four years earning her PhD at Aarhus University in Denmark, studying proteins called cargo receptors in Alzheimer’s disease.</p> <p>But then she stumbled upon the lab of <a href="/node/14871">Anna Greka</a>, a core institute member at the ӳý and a nephrologist at Mass General Brigham. The Greka lab studies the mechanisms behind protein trafficking inside cells, similar to what Monti researched in graduate school, but in the context of the kidney. Greka’s team had discovered that a family of cargo receptors called TMEDs traps misfolded proteins in the kidney, leading to kidney failure. They even found that this pathway also caused disease in the eye, suggesting that therapies developed to target this <a href="/news/molecular-traffic-jam-may-underlie-rare-kidney-disease-and-several-other-protein-misfolding">“node”</a> might be able to treat multiple diseases.</p> <p>Monti was intrigued by the parallels with her own work on misfolded proteins in neurodegeneration. She began to think about how she might study her original questions in a fresh context, beyond her usual area of expertise.</p> <p>“I thought that this was where I could learn the most,” said Monti, who is originally from Como, Italy, and completed a master’s degree in pharmacy at the University of Milan. “Being around researchers with different expertise challenged my thinking and broadened my learning in ways I had not anticipated. I love the idea of studying biology at its core, where the same basic principles can apply across different systems.”</p> <p>In December 2022, Monti moved to the US and joined the Greka lab as a postdoctoral associate. Today, she uses induced pluripotent stem (iPS) cells, mouse models, biochemical assays, and high-throughput screening to study the role of TMED cargo receptors in Alzheimer’s disease. She also collaborates with the lab of <a href="/node/1141681">Sam Peng</a> at ӳý, using single-particle tracking to visualize how proteins move inside neurons.</p> <p>We spoke with Monti about how her childhood curiosity evolved into her current interests in neuroscience and Alzheimer’s disease, and what drives her to seek new environments in this #WhyIScienceQ&A.</p> <p><strong>What got you interested in research?</strong></p> <p>Since I started school, I’ve been driven by wanting to understand how and why things happen.  For me, acquiring knowledge wasn’t just about school, it was how I could explore and make sense of the world.</p> <p>The brain has always fascinated me because it's been studied extensively and yet is still full of mysteries. I was deeply interested in biology and medicine, and I realized early on that my best fit was to directly work at the bench to contribute to the development of treatments for patients.  Science seemed to me the perfect outlet for my curiosity.</p> <p>During my undergrad, I had the opportunity to work in a lab where I actually realized that a career in research was not only possible but also incredibly rewarding. The curiosity-driven aspect of academic research appealed to me because it allows you to explore multiple paths. Of course, you want to help patients, and you need to steer your path with that goal in mind. But the idea that one can fundamentally ask any question to understand mechanistic biology — that's what made research the right path for me.</p> <p><strong>What are you working on right now?</strong></p> <p>We want to learn about nodal biology to translate it into something meaningful for Alzheimer’s patients. And we actually have some interesting results. We think the TMED cargo receptors previously discovered by the Greka lab also play a role in Alzheimer's disease. We found that they can bind to the amyloid precursor protein that’s known to be linked to Alzheimer’s disease. It seems that these cargo receptors are important for the trafficking of these amyloid proteins in the early secretory pathway, and therefore they can actually play a role not only in the trafficking of the protein, but also in the processing of amyloid itself, which ultimately leads to prevention of amyloid plaque deposition in the brain.</p> <p>This could be extremely meaningful for patients. Now that we have identified the target, we can begin to think more from a translational angle, exploring therapeutic possibilities that could alleviate the pathology also in Alzheimer’s patients.</p> <p><strong>What questions do you find most exciting in Alzheimer’s research today?</strong></p> <p>I think it's exciting to think about a major paradigm shift in Alzheimer's disease research. In the field, the vast majority of clinical trials focus on removing extracellular amyloid plaques deposited in the brain. However, this approach may target the disease at a stage that is already too advanced to observe substantial clinical benefits. Shifting the focus to alternative targets could redefine the way we think about the disease and treatment strategies. </p> <p>We should start looking more at the processes occurring inside neurons rather than just outside the cells, especially at the earliest stages of the disease. The amyloid in the extracellular space could be like the smoke and not the fire. Removing the smoke may provide temporary relief, but it won’t solve the problem in the long run if the fire continues to burn. By studying the early secretory pathways where proteins are sorted within the cell, even before reaching the late secretary stages that much of Alzheimer’s research currently targets — we would gain a lot of knowledge and possibly begin to shift the paradigm that way.</p> <p><strong>What advice would you give your younger self?</strong></p> <p>I would never have thought to be part of an institute such as the ӳý. I'm proud of the courage it took to leave my family and friends in Italy for grad school, and of how much I pushed myself along the way. During my PhD, I went to the University of Washington to learn from a lab that specialized in iPS cells for a couple of months. Even though it was a short stay, it had a big impact on me . I could actually see myself pursuing research in the US. The environment was incredibly inspiring, and it was energizing to be around people who are deeply passionate about what they do.</p> <p>And so I would advise: Do not fear change. Travel as much as you can for research, and try to experience as many different environments as you can. Don't be afraid of the challenge. You can gain a lot of knowledge from this experience. The reward will be so meaningful that the struggle will be less important.</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/neurodegeneration" hreflang="en">Neurodegeneration</a></div> <div class="field__item"><a href="/broad-tags/psychiatric-disease" hreflang="en">Brain Health</a></div> <div class="field__item"><a href="/broad-tags/anna-greka" hreflang="en">Anna Greka</a></div> </div> </div> </div> </div> </div> Tue, 14 Jan 2025 10:00:00 +0000 adicorat 5558086 at An immune factor in the brain plays critical roles in neuron function and aging /news/immune-factor-brain-plays-critical-roles-neuron-function-and-aging <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Allessandra DiCorato</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" class="datetime">June 16, 2025</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Giulia Monti reflects on how studying Alzheimer’s disease alongside researchers focused on kidney disease has helped her grow as a scientist.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Allessandra DiCorato </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" title="Monday, June 16, 2025 - 14:11" class="datetime">June 16, 2025</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1921px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=RibMLmfO 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/jpeg" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=9EVBDViv 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/jpeg" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=EfGmefhO 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/jpeg" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG 1x" media="all and (max-width: 539px)" type="image/jpeg" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG" alt="headshot of Giulia Monti" title="headshot of Giulia Monti" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__credit"> Credit: Allison Colorado, ӳý Communications </div> <div class="media-caption__description"> Giulia Monti studies Alzheimer's disease in the lab of Anna Greka. </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/2311/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/2311/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/2311/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--whyiscience-links paragraph--view-mode--default"> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p>At first, Giulia Monti thought she’d work in another neuroscience lab as a postdoctoral researcher. She had spent the last four years earning her PhD at Aarhus University in Denmark, studying proteins called cargo receptors in Alzheimer’s disease.</p> <p>But then she stumbled upon the lab of <a href="/node/14871">Anna Greka</a>, a core institute member at the ӳý and a nephrologist at Mass General Brigham. The Greka lab studies the mechanisms behind protein trafficking inside cells, similar to what Monti researched in graduate school, but in the context of the kidney. Greka’s team had discovered that a family of cargo receptors called TMEDs traps misfolded proteins in the kidney, leading to kidney failure. They even found that this pathway also caused disease in the eye, suggesting that therapies developed to target this <a href="/news/molecular-traffic-jam-may-underlie-rare-kidney-disease-and-several-other-protein-misfolding">“node”</a> might be able to treat multiple diseases.</p> <p>Monti was intrigued by the parallels with her own work on misfolded proteins in neurodegeneration. She began to think about how she might study her original questions in a fresh context, beyond her usual area of expertise.</p> <p>“I thought that this was where I could learn the most,” said Monti, who is originally from Como, Italy, and completed a master’s degree in pharmacy at the University of Milan. “Being around researchers with different expertise challenged my thinking and broadened my learning in ways I had not anticipated. I love the idea of studying biology at its core, where the same basic principles can apply across different systems.”</p> <p>In December 2022, Monti moved to the US and joined the Greka lab as a postdoctoral associate. Today, she uses induced pluripotent stem (iPS) cells, mouse models, biochemical assays, and high-throughput screening to study the role of TMED cargo receptors in Alzheimer’s disease. She also collaborates with the lab of <a href="/node/1141681">Sam Peng</a> at ӳý, using single-particle tracking to visualize how proteins move inside neurons.</p> <p>We spoke with Monti about how her childhood curiosity evolved into her current interests in neuroscience and Alzheimer’s disease, and what drives her to seek new environments in this #WhyIScienceQ&A.</p> <p><strong>What got you interested in research?</strong></p> <p>Since I started school, I’ve been driven by wanting to understand how and why things happen.  For me, acquiring knowledge wasn’t just about school, it was how I could explore and make sense of the world.</p> <p>The brain has always fascinated me because it's been studied extensively and yet is still full of mysteries. I was deeply interested in biology and medicine, and I realized early on that my best fit was to directly work at the bench to contribute to the development of treatments for patients.  Science seemed to me the perfect outlet for my curiosity.</p> <p>During my undergrad, I had the opportunity to work in a lab where I actually realized that a career in research was not only possible but also incredibly rewarding. The curiosity-driven aspect of academic research appealed to me because it allows you to explore multiple paths. Of course, you want to help patients, and you need to steer your path with that goal in mind. But the idea that one can fundamentally ask any question to understand mechanistic biology — that's what made research the right path for me.</p> <p><strong>What are you working on right now?</strong></p> <p>We want to learn about nodal biology to translate it into something meaningful for Alzheimer’s patients. And we actually have some interesting results. We think the TMED cargo receptors previously discovered by the Greka lab also play a role in Alzheimer's disease. We found that they can bind to the amyloid precursor protein that’s known to be linked to Alzheimer’s disease. It seems that these cargo receptors are important for the trafficking of these amyloid proteins in the early secretory pathway, and therefore they can actually play a role not only in the trafficking of the protein, but also in the processing of amyloid itself, which ultimately leads to prevention of amyloid plaque deposition in the brain.</p> <p>This could be extremely meaningful for patients. Now that we have identified the target, we can begin to think more from a translational angle, exploring therapeutic possibilities that could alleviate the pathology also in Alzheimer’s patients.</p> <p><strong>What questions do you find most exciting in Alzheimer’s research today?</strong></p> <p>I think it's exciting to think about a major paradigm shift in Alzheimer's disease research. In the field, the vast majority of clinical trials focus on removing extracellular amyloid plaques deposited in the brain. However, this approach may target the disease at a stage that is already too advanced to observe substantial clinical benefits. Shifting the focus to alternative targets could redefine the way we think about the disease and treatment strategies. </p> <p>We should start looking more at the processes occurring inside neurons rather than just outside the cells, especially at the earliest stages of the disease. The amyloid in the extracellular space could be like the smoke and not the fire. Removing the smoke may provide temporary relief, but it won’t solve the problem in the long run if the fire continues to burn. By studying the early secretory pathways where proteins are sorted within the cell, even before reaching the late secretary stages that much of Alzheimer’s research currently targets — we would gain a lot of knowledge and possibly begin to shift the paradigm that way.</p> <p><strong>What advice would you give your younger self?</strong></p> <p>I would never have thought to be part of an institute such as the ӳý. I'm proud of the courage it took to leave my family and friends in Italy for grad school, and of how much I pushed myself along the way. During my PhD, I went to the University of Washington to learn from a lab that specialized in iPS cells for a couple of months. Even though it was a short stay, it had a big impact on me . I could actually see myself pursuing research in the US. The environment was incredibly inspiring, and it was energizing to be around people who are deeply passionate about what they do.</p> <p>And so I would advise: Do not fear change. Travel as much as you can for research, and try to experience as many different environments as you can. Don't be afraid of the challenge. You can gain a lot of knowledge from this experience. The reward will be so meaningful that the struggle will be less important.</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/neurodegeneration" hreflang="en">Neurodegeneration</a></div> <div class="field__item"><a href="/broad-tags/psychiatric-disease" hreflang="en">Brain Health</a></div> <div class="field__item"><a href="/broad-tags/anna-greka" hreflang="en">Anna Greka</a></div> </div> </div> </div> </div> </div> Fri, 19 Jul 2024 13:42:09 +0000 tulrich@broadinstitute.org 5557141 at A therapy candidate for fatal prion diseases turns off disease-causing gene /news/therapy-candidate-fatal-prion-diseases-turns-disease-causing-gene <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Allessandra DiCorato</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" class="datetime">June 16, 2025</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Giulia Monti reflects on how studying Alzheimer’s disease alongside researchers focused on kidney disease has helped her grow as a scientist.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Allessandra DiCorato </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" title="Monday, June 16, 2025 - 14:11" class="datetime">June 16, 2025</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1921px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=RibMLmfO 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/jpeg" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=9EVBDViv 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/jpeg" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=EfGmefhO 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/jpeg" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG 1x" media="all and (max-width: 539px)" type="image/jpeg" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG" alt="headshot of Giulia Monti" title="headshot of Giulia Monti" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__credit"> Credit: Allison Colorado, ӳý Communications </div> <div class="media-caption__description"> Giulia Monti studies Alzheimer's disease in the lab of Anna Greka. </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/2311/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/2311/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/2311/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--whyiscience-links paragraph--view-mode--default"> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p>At first, Giulia Monti thought she’d work in another neuroscience lab as a postdoctoral researcher. She had spent the last four years earning her PhD at Aarhus University in Denmark, studying proteins called cargo receptors in Alzheimer’s disease.</p> <p>But then she stumbled upon the lab of <a href="/node/14871">Anna Greka</a>, a core institute member at the ӳý and a nephrologist at Mass General Brigham. The Greka lab studies the mechanisms behind protein trafficking inside cells, similar to what Monti researched in graduate school, but in the context of the kidney. Greka’s team had discovered that a family of cargo receptors called TMEDs traps misfolded proteins in the kidney, leading to kidney failure. They even found that this pathway also caused disease in the eye, suggesting that therapies developed to target this <a href="/news/molecular-traffic-jam-may-underlie-rare-kidney-disease-and-several-other-protein-misfolding">“node”</a> might be able to treat multiple diseases.</p> <p>Monti was intrigued by the parallels with her own work on misfolded proteins in neurodegeneration. She began to think about how she might study her original questions in a fresh context, beyond her usual area of expertise.</p> <p>“I thought that this was where I could learn the most,” said Monti, who is originally from Como, Italy, and completed a master’s degree in pharmacy at the University of Milan. “Being around researchers with different expertise challenged my thinking and broadened my learning in ways I had not anticipated. I love the idea of studying biology at its core, where the same basic principles can apply across different systems.”</p> <p>In December 2022, Monti moved to the US and joined the Greka lab as a postdoctoral associate. Today, she uses induced pluripotent stem (iPS) cells, mouse models, biochemical assays, and high-throughput screening to study the role of TMED cargo receptors in Alzheimer’s disease. She also collaborates with the lab of <a href="/node/1141681">Sam Peng</a> at ӳý, using single-particle tracking to visualize how proteins move inside neurons.</p> <p>We spoke with Monti about how her childhood curiosity evolved into her current interests in neuroscience and Alzheimer’s disease, and what drives her to seek new environments in this #WhyIScienceQ&A.</p> <p><strong>What got you interested in research?</strong></p> <p>Since I started school, I’ve been driven by wanting to understand how and why things happen.  For me, acquiring knowledge wasn’t just about school, it was how I could explore and make sense of the world.</p> <p>The brain has always fascinated me because it's been studied extensively and yet is still full of mysteries. I was deeply interested in biology and medicine, and I realized early on that my best fit was to directly work at the bench to contribute to the development of treatments for patients.  Science seemed to me the perfect outlet for my curiosity.</p> <p>During my undergrad, I had the opportunity to work in a lab where I actually realized that a career in research was not only possible but also incredibly rewarding. The curiosity-driven aspect of academic research appealed to me because it allows you to explore multiple paths. Of course, you want to help patients, and you need to steer your path with that goal in mind. But the idea that one can fundamentally ask any question to understand mechanistic biology — that's what made research the right path for me.</p> <p><strong>What are you working on right now?</strong></p> <p>We want to learn about nodal biology to translate it into something meaningful for Alzheimer’s patients. And we actually have some interesting results. We think the TMED cargo receptors previously discovered by the Greka lab also play a role in Alzheimer's disease. We found that they can bind to the amyloid precursor protein that’s known to be linked to Alzheimer’s disease. It seems that these cargo receptors are important for the trafficking of these amyloid proteins in the early secretory pathway, and therefore they can actually play a role not only in the trafficking of the protein, but also in the processing of amyloid itself, which ultimately leads to prevention of amyloid plaque deposition in the brain.</p> <p>This could be extremely meaningful for patients. Now that we have identified the target, we can begin to think more from a translational angle, exploring therapeutic possibilities that could alleviate the pathology also in Alzheimer’s patients.</p> <p><strong>What questions do you find most exciting in Alzheimer’s research today?</strong></p> <p>I think it's exciting to think about a major paradigm shift in Alzheimer's disease research. In the field, the vast majority of clinical trials focus on removing extracellular amyloid plaques deposited in the brain. However, this approach may target the disease at a stage that is already too advanced to observe substantial clinical benefits. Shifting the focus to alternative targets could redefine the way we think about the disease and treatment strategies. </p> <p>We should start looking more at the processes occurring inside neurons rather than just outside the cells, especially at the earliest stages of the disease. The amyloid in the extracellular space could be like the smoke and not the fire. Removing the smoke may provide temporary relief, but it won’t solve the problem in the long run if the fire continues to burn. By studying the early secretory pathways where proteins are sorted within the cell, even before reaching the late secretary stages that much of Alzheimer’s research currently targets — we would gain a lot of knowledge and possibly begin to shift the paradigm that way.</p> <p><strong>What advice would you give your younger self?</strong></p> <p>I would never have thought to be part of an institute such as the ӳý. I'm proud of the courage it took to leave my family and friends in Italy for grad school, and of how much I pushed myself along the way. During my PhD, I went to the University of Washington to learn from a lab that specialized in iPS cells for a couple of months. Even though it was a short stay, it had a big impact on me . I could actually see myself pursuing research in the US. The environment was incredibly inspiring, and it was energizing to be around people who are deeply passionate about what they do.</p> <p>And so I would advise: Do not fear change. Travel as much as you can for research, and try to experience as many different environments as you can. Don't be afraid of the challenge. You can gain a lot of knowledge from this experience. The reward will be so meaningful that the struggle will be less important.</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/neurodegeneration" hreflang="en">Neurodegeneration</a></div> <div class="field__item"><a href="/broad-tags/psychiatric-disease" hreflang="en">Brain Health</a></div> <div class="field__item"><a href="/broad-tags/anna-greka" hreflang="en">Anna Greka</a></div> </div> </div> </div> </div> </div> Thu, 27 Jun 2024 18:11:10 +0000 Corie Lok 5557021 at Calico and ӳý extend collaboration, adding focus on age-related neurodegeneration /news/calico-and-broad-institute-extend-collaboration-adding-focus-age-related-neurodegeneration <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Allessandra DiCorato</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" class="datetime">June 16, 2025</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Giulia Monti reflects on how studying Alzheimer’s disease alongside researchers focused on kidney disease has helped her grow as a scientist.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Allessandra DiCorato </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" title="Monday, June 16, 2025 - 14:11" class="datetime">June 16, 2025</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1921px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=RibMLmfO 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/jpeg" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=9EVBDViv 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/jpeg" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=EfGmefhO 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/jpeg" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG 1x" media="all and (max-width: 539px)" type="image/jpeg" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG" alt="headshot of Giulia Monti" title="headshot of Giulia Monti" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__credit"> Credit: Allison Colorado, ӳý Communications </div> <div class="media-caption__description"> Giulia Monti studies Alzheimer's disease in the lab of Anna Greka. </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/2311/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/2311/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/2311/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--whyiscience-links paragraph--view-mode--default"> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p>At first, Giulia Monti thought she’d work in another neuroscience lab as a postdoctoral researcher. She had spent the last four years earning her PhD at Aarhus University in Denmark, studying proteins called cargo receptors in Alzheimer’s disease.</p> <p>But then she stumbled upon the lab of <a href="/node/14871">Anna Greka</a>, a core institute member at the ӳý and a nephrologist at Mass General Brigham. The Greka lab studies the mechanisms behind protein trafficking inside cells, similar to what Monti researched in graduate school, but in the context of the kidney. Greka’s team had discovered that a family of cargo receptors called TMEDs traps misfolded proteins in the kidney, leading to kidney failure. They even found that this pathway also caused disease in the eye, suggesting that therapies developed to target this <a href="/news/molecular-traffic-jam-may-underlie-rare-kidney-disease-and-several-other-protein-misfolding">“node”</a> might be able to treat multiple diseases.</p> <p>Monti was intrigued by the parallels with her own work on misfolded proteins in neurodegeneration. She began to think about how she might study her original questions in a fresh context, beyond her usual area of expertise.</p> <p>“I thought that this was where I could learn the most,” said Monti, who is originally from Como, Italy, and completed a master’s degree in pharmacy at the University of Milan. “Being around researchers with different expertise challenged my thinking and broadened my learning in ways I had not anticipated. I love the idea of studying biology at its core, where the same basic principles can apply across different systems.”</p> <p>In December 2022, Monti moved to the US and joined the Greka lab as a postdoctoral associate. Today, she uses induced pluripotent stem (iPS) cells, mouse models, biochemical assays, and high-throughput screening to study the role of TMED cargo receptors in Alzheimer’s disease. She also collaborates with the lab of <a href="/node/1141681">Sam Peng</a> at ӳý, using single-particle tracking to visualize how proteins move inside neurons.</p> <p>We spoke with Monti about how her childhood curiosity evolved into her current interests in neuroscience and Alzheimer’s disease, and what drives her to seek new environments in this #WhyIScienceQ&A.</p> <p><strong>What got you interested in research?</strong></p> <p>Since I started school, I’ve been driven by wanting to understand how and why things happen.  For me, acquiring knowledge wasn’t just about school, it was how I could explore and make sense of the world.</p> <p>The brain has always fascinated me because it's been studied extensively and yet is still full of mysteries. I was deeply interested in biology and medicine, and I realized early on that my best fit was to directly work at the bench to contribute to the development of treatments for patients.  Science seemed to me the perfect outlet for my curiosity.</p> <p>During my undergrad, I had the opportunity to work in a lab where I actually realized that a career in research was not only possible but also incredibly rewarding. The curiosity-driven aspect of academic research appealed to me because it allows you to explore multiple paths. Of course, you want to help patients, and you need to steer your path with that goal in mind. But the idea that one can fundamentally ask any question to understand mechanistic biology — that's what made research the right path for me.</p> <p><strong>What are you working on right now?</strong></p> <p>We want to learn about nodal biology to translate it into something meaningful for Alzheimer’s patients. And we actually have some interesting results. We think the TMED cargo receptors previously discovered by the Greka lab also play a role in Alzheimer's disease. We found that they can bind to the amyloid precursor protein that’s known to be linked to Alzheimer’s disease. It seems that these cargo receptors are important for the trafficking of these amyloid proteins in the early secretory pathway, and therefore they can actually play a role not only in the trafficking of the protein, but also in the processing of amyloid itself, which ultimately leads to prevention of amyloid plaque deposition in the brain.</p> <p>This could be extremely meaningful for patients. Now that we have identified the target, we can begin to think more from a translational angle, exploring therapeutic possibilities that could alleviate the pathology also in Alzheimer’s patients.</p> <p><strong>What questions do you find most exciting in Alzheimer’s research today?</strong></p> <p>I think it's exciting to think about a major paradigm shift in Alzheimer's disease research. In the field, the vast majority of clinical trials focus on removing extracellular amyloid plaques deposited in the brain. However, this approach may target the disease at a stage that is already too advanced to observe substantial clinical benefits. Shifting the focus to alternative targets could redefine the way we think about the disease and treatment strategies. </p> <p>We should start looking more at the processes occurring inside neurons rather than just outside the cells, especially at the earliest stages of the disease. The amyloid in the extracellular space could be like the smoke and not the fire. Removing the smoke may provide temporary relief, but it won’t solve the problem in the long run if the fire continues to burn. By studying the early secretory pathways where proteins are sorted within the cell, even before reaching the late secretary stages that much of Alzheimer’s research currently targets — we would gain a lot of knowledge and possibly begin to shift the paradigm that way.</p> <p><strong>What advice would you give your younger self?</strong></p> <p>I would never have thought to be part of an institute such as the ӳý. I'm proud of the courage it took to leave my family and friends in Italy for grad school, and of how much I pushed myself along the way. During my PhD, I went to the University of Washington to learn from a lab that specialized in iPS cells for a couple of months. Even though it was a short stay, it had a big impact on me . I could actually see myself pursuing research in the US. The environment was incredibly inspiring, and it was energizing to be around people who are deeply passionate about what they do.</p> <p>And so I would advise: Do not fear change. Travel as much as you can for research, and try to experience as many different environments as you can. Don't be afraid of the challenge. You can gain a lot of knowledge from this experience. The reward will be so meaningful that the struggle will be less important.</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/neurodegeneration" hreflang="en">Neurodegeneration</a></div> <div class="field__item"><a href="/broad-tags/psychiatric-disease" hreflang="en">Brain Health</a></div> <div class="field__item"><a href="/broad-tags/anna-greka" hreflang="en">Anna Greka</a></div> </div> </div> </div> </div> </div> Thu, 09 May 2024 12:30:10 +0000 Corie Lok 5556886 at Scientists reveal cellular changes unique to early Alzheimer’s disease /news/scientists-reveal-cellular-changes-unique-early-alzheimers-disease <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Allessandra DiCorato</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" class="datetime">June 16, 2025</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Giulia Monti reflects on how studying Alzheimer’s disease alongside researchers focused on kidney disease has helped her grow as a scientist.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Allessandra DiCorato </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2025-06-16T14:11:15-04:00" title="Monday, June 16, 2025 - 14:11" class="datetime">June 16, 2025</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1921px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=jrRo7ynz 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/jpeg" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=RibMLmfO 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/jpeg" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=9EVBDViv 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/jpeg" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=EfGmefhO 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/jpeg" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG 1x" media="all and (max-width: 539px)" type="image/jpeg" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/Giulia_Monti_2025-4_main.jpg?h=8c1344d8&itok=f3t9K3DG" alt="headshot of Giulia Monti" title="headshot of Giulia Monti" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__credit"> Credit: Allison Colorado, ӳý Communications </div> <div class="media-caption__description"> Giulia Monti studies Alzheimer's disease in the lab of Anna Greka. </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/2311/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/2311/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/2311/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--whyiscience-links paragraph--view-mode--default"> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p>At first, Giulia Monti thought she’d work in another neuroscience lab as a postdoctoral researcher. She had spent the last four years earning her PhD at Aarhus University in Denmark, studying proteins called cargo receptors in Alzheimer’s disease.</p> <p>But then she stumbled upon the lab of <a href="/node/14871">Anna Greka</a>, a core institute member at the ӳý and a nephrologist at Mass General Brigham. The Greka lab studies the mechanisms behind protein trafficking inside cells, similar to what Monti researched in graduate school, but in the context of the kidney. Greka’s team had discovered that a family of cargo receptors called TMEDs traps misfolded proteins in the kidney, leading to kidney failure. They even found that this pathway also caused disease in the eye, suggesting that therapies developed to target this <a href="/news/molecular-traffic-jam-may-underlie-rare-kidney-disease-and-several-other-protein-misfolding">“node”</a> might be able to treat multiple diseases.</p> <p>Monti was intrigued by the parallels with her own work on misfolded proteins in neurodegeneration. She began to think about how she might study her original questions in a fresh context, beyond her usual area of expertise.</p> <p>“I thought that this was where I could learn the most,” said Monti, who is originally from Como, Italy, and completed a master’s degree in pharmacy at the University of Milan. “Being around researchers with different expertise challenged my thinking and broadened my learning in ways I had not anticipated. I love the idea of studying biology at its core, where the same basic principles can apply across different systems.”</p> <p>In December 2022, Monti moved to the US and joined the Greka lab as a postdoctoral associate. Today, she uses induced pluripotent stem (iPS) cells, mouse models, biochemical assays, and high-throughput screening to study the role of TMED cargo receptors in Alzheimer’s disease. She also collaborates with the lab of <a href="/node/1141681">Sam Peng</a> at ӳý, using single-particle tracking to visualize how proteins move inside neurons.</p> <p>We spoke with Monti about how her childhood curiosity evolved into her current interests in neuroscience and Alzheimer’s disease, and what drives her to seek new environments in this #WhyIScienceQ&A.</p> <p><strong>What got you interested in research?</strong></p> <p>Since I started school, I’ve been driven by wanting to understand how and why things happen.  For me, acquiring knowledge wasn’t just about school, it was how I could explore and make sense of the world.</p> <p>The brain has always fascinated me because it's been studied extensively and yet is still full of mysteries. I was deeply interested in biology and medicine, and I realized early on that my best fit was to directly work at the bench to contribute to the development of treatments for patients.  Science seemed to me the perfect outlet for my curiosity.</p> <p>During my undergrad, I had the opportunity to work in a lab where I actually realized that a career in research was not only possible but also incredibly rewarding. The curiosity-driven aspect of academic research appealed to me because it allows you to explore multiple paths. Of course, you want to help patients, and you need to steer your path with that goal in mind. But the idea that one can fundamentally ask any question to understand mechanistic biology — that's what made research the right path for me.</p> <p><strong>What are you working on right now?</strong></p> <p>We want to learn about nodal biology to translate it into something meaningful for Alzheimer’s patients. And we actually have some interesting results. We think the TMED cargo receptors previously discovered by the Greka lab also play a role in Alzheimer's disease. We found that they can bind to the amyloid precursor protein that’s known to be linked to Alzheimer’s disease. It seems that these cargo receptors are important for the trafficking of these amyloid proteins in the early secretory pathway, and therefore they can actually play a role not only in the trafficking of the protein, but also in the processing of amyloid itself, which ultimately leads to prevention of amyloid plaque deposition in the brain.</p> <p>This could be extremely meaningful for patients. Now that we have identified the target, we can begin to think more from a translational angle, exploring therapeutic possibilities that could alleviate the pathology also in Alzheimer’s patients.</p> <p><strong>What questions do you find most exciting in Alzheimer’s research today?</strong></p> <p>I think it's exciting to think about a major paradigm shift in Alzheimer's disease research. In the field, the vast majority of clinical trials focus on removing extracellular amyloid plaques deposited in the brain. However, this approach may target the disease at a stage that is already too advanced to observe substantial clinical benefits. Shifting the focus to alternative targets could redefine the way we think about the disease and treatment strategies. </p> <p>We should start looking more at the processes occurring inside neurons rather than just outside the cells, especially at the earliest stages of the disease. The amyloid in the extracellular space could be like the smoke and not the fire. Removing the smoke may provide temporary relief, but it won’t solve the problem in the long run if the fire continues to burn. By studying the early secretory pathways where proteins are sorted within the cell, even before reaching the late secretary stages that much of Alzheimer’s research currently targets — we would gain a lot of knowledge and possibly begin to shift the paradigm that way.</p> <p><strong>What advice would you give your younger self?</strong></p> <p>I would never have thought to be part of an institute such as the ӳý. I'm proud of the courage it took to leave my family and friends in Italy for grad school, and of how much I pushed myself along the way. During my PhD, I went to the University of Washington to learn from a lab that specialized in iPS cells for a couple of months. Even though it was a short stay, it had a big impact on me . I could actually see myself pursuing research in the US. The environment was incredibly inspiring, and it was energizing to be around people who are deeply passionate about what they do.</p> <p>And so I would advise: Do not fear change. Travel as much as you can for research, and try to experience as many different environments as you can. Don't be afraid of the challenge. You can gain a lot of knowledge from this experience. The reward will be so meaningful that the struggle will be less important.</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/neurodegeneration" hreflang="en">Neurodegeneration</a></div> <div class="field__item"><a href="/broad-tags/psychiatric-disease" hreflang="en">Brain Health</a></div> <div class="field__item"><a href="/broad-tags/anna-greka" hreflang="en">Anna Greka</a></div> </div> </div> </div> </div> </div> Thu, 28 Sep 2023 15:00:00 +0000 adicorat 5555746 at